Phil Shackley
BA MSc PhD
Population Health, School of Medicine and Population Health
Reader in Health Economics
p.shackley@sheffield.ac.uk
+44 114 222 2992
+44 114 222 2992
Regent Court (ScHARR)
Full contact details
Phil Shackley
Population Health, School of Medicine and Population Health
Regent Court (ScHARR)
30 Regent Street
Sheffield
S1 4DA
Population Health, School of Medicine and Population Health
Regent Court (ScHARR)
30 Regent Street
Sheffield
S1 4DA
- Profile
-
I was appointed Reader in Health Economics in January 2012, having previously held Senior Lecturer appointments at the Universities of Sheffield (2006-2011) and Newcastle (2002-2006). Prior to that I worked as a Lecturer at the University of Sheffield (1996–2002) and as a Research Fellow at the University of Aberdeen (1991–1996).
- Research interests
-
Developing and applying the contingent valuation methodology, in particular the technique of willingness to pay.
Applications include: estimating the social value of a quality adjusted life year (QALY); using willingness to pay values to aid priority setting in publicly-financed health care systems; investigating how willingness to pay can and should be used alongside randomised trials; the use of willingness to pay to evaluate the benefits of public health interventions such as the fluoridation of drinking water supplies and the supplementation of flour with folic acid; evaluating minimally invasive surgery; assessing patient preferences for diagnostic radiology; and assessing preferences for an expanded newborn screening programme.
The identification, measurement and valuation of (dis)benefits that are not captured in the QALY approach.
Applications include: assessing the value of patient health cards; eliciting patient preferences for out-of-hours primary care services; establishing and quantifying the preferences of mental health service users for day hospital care; eliciting patient preferences for the organisation of vascular services; and assessing preferences for access to a general practitioner.
The application of economic evaluation techniques to assess the efficiency of health care programmes and interventions.
Applications include: screening in primary care; antenatal screening; management of lower respiratory tract infection in general practice; computerised cognitive behavioural therapy for anxiety and depression; methods for assessing patients with intermittent claudication; drug treatments for epilepsy; stroke incidence and prevention in Tanzania; venous leg ulcers; and treating upper limb spasticity due to stroke with botulinum toxin.
Current projects
- Examining the feasibility of measuring process utilities associated with different models of care for obese leg ulcer patients.
- The design, development, commissioning and evaluation of patient focused vascular services.
- Evaluation of workplace interventions for long latency diseases.
- Publications
-
Show: Featured publications All publications
Featured publications
Journal articles
- Eliciting Societal Preferences for Weighting QALYs for Burden of Illness and End of Life. Medical Decision Making, 36(2), 210-222.
- The random card sort method and respondent certainty in contingent valuation: An exploratory investigation of range bias. Health Economics (United Kingdom).
- Cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type a: Results from the botulinum toxin for the upper limb after stroke (BoTULS) trial. Toxins, 4(12), 1415-1426. View this article in WRRO
- The social value of a QALY: raising the bar or barring the raise?. BMC Health Serv Res, 11, 8. View this article in WRRO
- Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial: effect on impairment, activity limitation, and pain.. Stroke, 42(5), 1371-1379.
- Randomized controlled trial and cost-effectiveness analysis of silver-donating antimicrobial dressings for venous leg ulcers (VULCAN trial).. Br J Surg, 96(10), 1147-1156.
- The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. LANCET, 369(9566), 1016-1026.
- The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. LANCET, 369(9566), 1000-1015.
- Should we use willingness to pay to elicit community preferences for health care? New evidence from using a 'marginal' approach.. J Health Econ, 21(6), 971-991.
- Do ordering effects matter in willingness-to-pay studies of health care?. J Health Econ, 21(4), 585-599.
All publications
Journal articles
- Managing the delivery of venous leg ulcer services : a willingness to pay study. Health Science Reports, 5(4).
- Patient preferences for treatment in steroid resistant ulcerative colitis – a discrete-choice experiment. Scandinavian Journal of Gastroenterology.
- P244 Clinician preferences in treating steroid resistant ulcerative colitis: a discrete-choice experiment (DCE) survey. Journal of Crohn's and Colitis, 15(Supplement_1), s287-s287.
- P176 Patient preferences in steroid resistant ulcerative colitis – a discrete choice experiment survey. Journal of Crohn's and Colitis, 15(Supplement_1), s249-s249.
- Configuration of vascular services : a multiple methods research programme. Programme Grants for Applied Research, 9(5), 1-150. View this article in WRRO
- Author response to: Comment on: Strength of public preferences for endovascular or open aortic aneurysm repair. British Journal of Surgery, 107(5), 613-614.
- Strength of public preferences for endovascular or open aortic aneurysm repair. British Journal of Surgery, 106(13), 1775-1783. View this article in WRRO
- Long-term survival after endovascular and open repair of unruptured abdominal aortic aneurysm.. Br J Surg, 106(13), 1784-1793.
- The Relationship between Hospital or Surgeon Volume and Outcomes in Lower Limb Vascular Surgery in the United Kingdom and Europe. Annals of Vascular Surgery, 45, 271-286. View this article in WRRO
- Systematic review of carotid artery procedures and the volume–outcome relationship in Europe. British Journal of Surgery, 104(10), 1273-1283. View this article in WRRO
- Procedure Volume and the Association with Short-term Mortality Following Abdominal Aortic Aneurysm Repair in European Populations: A Systematic Review. European Journal of Vascular and Endovascular Surgery, 53(1), 77-88. View this article in WRRO
- From representing views to representativeness of views: Illustrating a new (Q2S) approach in the context of health care priority setting in nine European countries. Social Science and Medicine, 166, 205-213. View this article in WRRO
- The relationship between hospital or surgeon volume and outcomes in lower limb vascular surgery in Europe. HTAi 2016 Abstract Book (ISUU), 131-`32.
- Eliciting Societal Preferences for Weighting QALYs for Burden of Illness and End of Life. Medical Decision Making, 36(2), 210-222.
- A qualitative study to explore the attitude of clinical staff to the challenges of caring for obese patients. Journal of Clinical Nursing, 24(23-24), 3594-3604. View this article in WRRO
- Comparing WTP Values of Different Types of QALY Gain Elicited from the General Public. Health Economics, 24(3), 280-293.
- Public views on principles for health care priority setting: Findings of a European cross-country study using Q methodology. Social Science & Medicine, 126, 128-137.
- The random card sort method and respondent certainty in contingent valuation: An exploratory investigation of range bias. Health Economics (United Kingdom).
- Estimating a WTP-based value of a QALY: The ‘chained’ approach. Social Science & Medicine, 92, 92-104.
- The cost of treating stroke in urban and rural Tanzania: A 6-month pilot study. African Journal of Neurological Sciences, 32(2).
- Cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type a: Results from the botulinum toxin for the upper limb after stroke (BoTULS) trial. Toxins, 4(12), 1415-1426. View this article in WRRO
- Contingent valuation in health care, 425-434.
- Putting a value on the avoidance of false positive results when screening for inherited metabolic disease in the newborn.. J Inherit Metab Dis, 35(1), 169-176.
- The social value of a QALY: raising the bar or barring the raise?. BMC Health Serv Res, 11, 8. View this article in WRRO
- Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial: effect on impairment, activity limitation, and pain.. Stroke, 42(5), 1371-1379.
- BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.. Health technology assessment (Winchester, England), 14(26).
- Weighting and valuing quality-adjusted life-years using stated preference methods: preliminary results from the Social Value of a QALY Project.. Health technology assessment (Winchester, England), 14(27), 1-162.
- BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.. Health Technol Assess, 14(26), 1-iv.
- Weighting and valuing quality-adjusted life-years using stated preference methods: preliminary results from the Social Value of a QALY Project.. Health Technol Assess, 14(27), 1-162.
- Assessing current health-related quality of life questionnaires administered to patients with venous ulcers: can they be used in economic evaluations?. J CLIN NURS, 19(5-6), 892-897.
- A prospective randomised controlled trial and economic modelling of antimicrobial silver dressings versus non-adherent control dressings for venous leg ulcers: the VULCAN trial.. Health Technol Assess, 13(56), 1-iii.
- Evaluation of the cost-effectiveness of root canal treatment using conventional approaches versus replacement with an implant.. Int Endod J, 42(10), 874-883.
- Randomized controlled trial and cost-effectiveness analysis of silver-donating antimicrobial dressings for venous leg ulcers (VULCAN trial).. Br J Surg, 96(10), 1147-1156.
- Randomised controlled trial of anti-microbial agents for the treatment of venous leg ulcers. British Journal of Surgery, 96(S1), 15-15.
- Study design and methods of the BoTULS trial: a randomised controlled trial to evaluate the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.. Trials, 9, 59. View this article in WRRO
- A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.. Health Technol Assess, 11(37), iii-134.
- A comparison of the 'cost per child treated' at a primary care-based sedation referral service, compared to a general anaesthetic in hospital.. Br Dent J, 203(6), E13.
- The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. LANCET, 369(9566), 1016-1026.
- The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. LANCET, 369(9566), 1000-1015.
- Preferences for access to the GP: a discrete choice experiment.. Br J Gen Pract, 56(531), 743-748.
- Implicit versus explicit ranking: on inferring ordinal preferences for health care programmes based on differences in willingness-to-pay.. J Health Econ, 24(5), 990-996.
- Willingness to pay for public health care: a comparison of two approaches.. Health Policy, 70(2), 217-228.
- The impact of information on non-health attributes on willingness to pay for multiple health care programmes.. Soc Sci Med, 58(7), 1257-1269.
- The use of willingness to pay to assess public preferences towards the fortification of foodstuffs with folic acid.. Health Expect, 6(2), 140-148.
- Should we use willingness to pay to elicit community preferences for health care? New evidence from using a 'marginal' approach.. J Health Econ, 21(6), 971-991.
- Do ordering effects matter in willingness-to-pay studies of health care?, 21(4), 585-599.
- Do ordering effects matter in willingness-to-pay studies of health care?. J Health Econ, 21(4), 585-599.
- Establishing and quantifying the preferences of mental health service users for day hospital care: A pilot study using conjoint analysis. Journal of Mental Health, 11(1), 85-96.
- A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxiety. Health Technology Assessment, 6(22). View this article in WRRO
- Vascular patients' preferences for local treatment: an application of conjoint analysis.. J Health Serv Res Policy, 6(3), 151-157.
- Eliciting preferences for resource allocation in health care. Economic and Social Review, 32(3), 217-238.
- Willingness to pay for publicly-financed health care: how should we use the numbers?. APPL ECON, 32(15), 2015-2021.
- REVIEW ARTICLE: Is there a Positive Volume–Outcome Relationship in Peripheral Vascular Surgery? Results of a Systematic Review. European Journal of Vascular and Endovascular Surgery, 20(4), 326-335.
- Quantifying patient preferences for out-of-hours primary care.. J Health Serv Res Policy, 5(4), 214-218.
- Is there a positive volume-outcome relationship in peripheral vascular surgery? Results of a systematic review.. Eur J Vasc Endovasc Surg, 20(4), 326-335.
- Using contingent valuation to elicit public preferences for water fluoridation. APPL ECON, 32(6), 777-787.
- Modelling the effects of the reorganization of vascular services. British Journal of Surgery, 87(4), 515-515.
- Cost and outcome implications of the organisation of vascular services. Health Technology Assessment, 4(11).
- Costing vascular surgery: A review of current reporting practice.. J Vasc Surg, 30(4), 668-678.
- What price information? Modelling threshold probabilities of fetal loss.. Soc Sci Med, 49(6), 823-830.
- Estimating the benefits of community water fluoridation using the willingness-to-pay technique: results of a pilot study.. Community Dent Oral Epidemiol, 27(2), 124-129.
- Using conjoint analysis to elicit the views of health service users: an application to the patient health card.. Health Expect, 1(2), 117-129.
- Methodological issues in the application of conjoint analysis in health care.. Health Econ, 7(4), 373-378.
- Estimating the benefits of community water fluoridation using the willingness-to-pay technique: results of a pilot study. Community Dentistry and Oral Epidemiology, 27(2), 124-129.
- Book Review. European Journal of Vascular and Endovascular Surgery, 15(3), 275-276.
- Accelerated bacteriological evaluation in the management of lower respiratory tract infection in general practice.. J Antimicrob Chemother, 39(5), 663-666.
- Using willingness to pay to value close substitutes: carrier screening for cystic fibrosis revisited.. Health Econ, 6(2), 145-159.
- Does "process utility" exist? A case study of willingness to pay for laparoscopic cholecystectomy.. Soc Sci Med, 44(5), 699-707.
- Economic evaluation of prenatal diagnosis: a methodological review.. Prenat Diagn, 16(5), 389-395.
- Evaluating the benefits of antenatal screening: an alternative approach.. Health Policy, 36(2), 103-115.
- Decision making with respect to diagnostic testing: a method of valuing the benefits of antenatal screening.. Med Decis Making, 16(2), 161-168.
- Health economics. The dog in the manger?. Lancet, 346 Suppl, s10.
- Willingness to pay for antenatal carrier screening for cystic fibrosis.. Health Econ, 4(6), 439-452.
- Assessing the benefits of health care: how far should we go?. Qual Health Care, 4(3), 207-213.
- Involving consumers in health care decision making.. Health Care Anal, 3(3), 196-204.
- Stepwise or couple antenatal carrier screening for cystic fibrosis?: women's preferences and willingness to pay.. J Med Genet, 32(4), 282-283.
- WHAT IS THE ROLE OF THE CONSUMER IN HEALTH-CARE. J SOC POLICY, 23, 517-541.
- Market and Health by David Resiman. The Macmillan Press Ltd. London, 1993. No. of pages: 254. ISBN 0‐333‐59480‐0. Health Economics, 3(3), 207-207.
- MARKET AND HEALTH - REISMAN,D. HEALTH ECON, 3(3), 207-207.
- Counting the benefits of screening: a pilot study of willingness to pay for cystic fibrosis carrier screening.. J Med Screen, 1(2), 82-83.
- Reply. Journal of Public Health, 16(1), 116-117.
- Pre-natal screening for down’s syndrome. Journal of Public Health (United Kingdom), 16(1), 114-115.
- Assessing value for money in medical screening.. J Med Screen, 1(1), 39-44.
- Prevention in primary care: the annual assessment of elderly people.. Health Policy, 25(1-2), 51-62.
- Creating a market: an economic analysis of the purchaser-provider model.. Health Policy, 25(1-2), 153-168.
- An economic appraisal of alternative pre-natal screening programmes for Down's syndrome.. J Public Health Med, 15(2), 175-184.
- Sometimes sensitive, seldom specific: a review of the economics of screening.. Health Econ, 2(1), 43-53.
- The contribution of economics to screening in health care. European Journal of Public Health, 2(2), 105-112.
- Patient preferences for pilonidal sinus treatments: a discrete choice experiment survey. Colorectal Disease.
- Patient preferences and current practice for adults with steroid-resistant ulcerative colitis: POPSTER mixed-methods study. Health Technology Assessment, 26(41), 1-118.
- Carotid artery procedures and the volume-outcome relationship in Europe: a systematic review. British Journal of Surgery.
- The PITSTOP Study: PIlonidal sinus Treatment: STudying the OPtions - Protocol.
Chapters
- Using Conjoint Analysis and Willingness to Pay to Determine Consumers’ Preferences for Health Care, Researching Health Care Consumers (pp. 71-93). Macmillan Education UK
- Public Attitudes to Participating in UK BioBank: A DNA Bank, Lifestyle and Morbidity Database on 500,000 Members of the UK Public Aged 45-69, Populations and Genetics (pp. 323-342). Brill | Nijhoff
- Contingent Valuation in Health Care Edward Elgar Publishing
Conference proceedings papers
- P97 Management of steroid resistant ulcerative colitis – a national survey of UK practice. Posters
- P96 Factors influencing treatment preferences in steroid resistant ulcerative colitis – a qualitative interview study (pp a90.2-a9a91)
- PCV153 - ELICITING PUBLIC PREFERENCES FOR REORGANIZATION OF VASCULAR SERVICES IN THE UK. Value in Health, Vol. 21 (pp S117-S117)
- Using public preferences to quantify the burden of travel to specialist vascular centres for abdominal aortic aneurysm treatment in the UK. RCN International Research Conference
- Comparison of the shuttle-walk and treadmill exercise tests for assessing patients with peripheral arterial disease. BRITISH JOURNAL OF SURGERY, Vol. 90(4) (pp 502-503)
- Willingness to pay for health care. ADVANCES IN HEALTH ECONOMICS (pp 1-24)
Website content
- Volume-outcome relationships in peripheral vascular surgery: a systematic review (protocol no. CRD42014014850 registered on PROSPERO).
Scholarly editions
- Do Ordering Effects Matter in Willingness-to-pay Studies of Health Care?.
- The impact of information on non-health attributes on willingness to pay for multiple health care programmes.
Posters
- #20 Design and rationale of the PIlonidal sinus Treatment - STudying the OPtions (PITSTOP) study: a multicentre cohort, nested mixed-methods case study and discrete choice experiment (poster presentation).
- Searching for evidence for systematic reviews of volume outcome relationship in peripheral vascular surgery. 2016 HTAi Annual meeting, Tokyo Japan.
- Volume-outcome relationships in peripheral vascular surgery: an overview of reviews. Health Technology Assessment International (Tokyo).
- Volume-outcome relationships in the treatment of AAA in Europe: a systematic review. Health Technology Assessment International (Tokyo).
Other
- Comment on: Strength of public preferences for endovascular or open aortic aneurysm repair. British Journal of Surgery, 107(5), 613-613.
- Randomized controlled trial and cost-effectiveness analysis of silver-donating antimicrobial dressings for venous leg ulcers (VULCAN trial) (Br J Surg 2009; 96: 1147-1156) Reply. BRIT J SURG, 97(3), 460-460.
- Eliciting Societal Preferences for Weighting QALYs for Burden of Illness and End of Life. Medical Decision Making, 36(2), 210-222.
- Teaching interests
-
I teach health economics on a number of modules on MSc Health Economics and Decision Modelling, and MSc International Health Technology Assessment and Reimbursement.
I am the Director of Teaching for HEDS and the Academic Lead for Teaching Quality for ScHARR.
I am interested in supervising research students in topics related to my research interests above.
- Professional activities and memberships
-
- Member of the Higher Education Academy (formerly the Institute for Learning and Teaching in Higher Education)
- Member of the UK Health Economists' Study Group
- Member of the International Health Economics Association